Global Piracetam Injection Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Piracetam Injection Market Insights, Forecast to 2034
It is suitable for memory loss and mild to moderate brain dysfunction caused by various reasons such as acute and chronic cerebrovascular diseases, brain trauma, and various toxic encephalopathy. It is also used for children with mental retardation.
Global Piracetam Injection market is expected to reach to US$ 3599 million in 2023, with a positive growth of %, compared with US$ 2608 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Piracetam Injection industry is evaluated to reach US$ 24110 million in 2034. The CAGR will be 37.3% during 2023 to 2034.
Brain diseases have always been one of the most difficult areas for human beings to conquer. There are constant disputes over whether neuroprotective agents are life-saving drugs or panacea. The neuroprotective drug market is greatly influenced by evidence-based drug use and related policies. New drugs such as butylphthalide and edaravone dexaborneol are developing rapidly, and after the decline of many old drugs such as edaravone, oxiracetam, and gangliosides, they have taken over and become Dinghaishenzhen among neuroprotective drugs. In addition, piracetam, which is a gamma-aminobutyric acid analogue like oxiracetam, has also been recommended by multiple guidelines, bucking the trend and achieving market growth.
Report Covers
This report presents an overview of global Piracetam Injection market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Piracetam Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical
Chongqing Yaoyou Pharmaceutical
Harbin Pharmaceutical Group Sanjing Pharmaceutical
Yangzhou Pharmaceutical
Rapid Life Drugs & Healthcare
Mits Healthcare Private Limited
Psychocare
Shinepro Lifesciences Pvt. Ltd.
REPLEK FARM DOOEL
Dr Reddy's Laboratories Ltd
Heilongjiang Fuhe Pharmaceutical
Segment by Type
15ml
60mL
Other
Hospital
Clinic
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Piracetam Injection plant distribution, commercial date of Piracetam Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Piracetam Injection introduction, etc. Piracetam Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Piracetam Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Piracetam Injection market is expected to reach to US$ 3599 million in 2023, with a positive growth of %, compared with US$ 2608 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Piracetam Injection industry is evaluated to reach US$ 24110 million in 2034. The CAGR will be 37.3% during 2023 to 2034.
Brain diseases have always been one of the most difficult areas for human beings to conquer. There are constant disputes over whether neuroprotective agents are life-saving drugs or panacea. The neuroprotective drug market is greatly influenced by evidence-based drug use and related policies. New drugs such as butylphthalide and edaravone dexaborneol are developing rapidly, and after the decline of many old drugs such as edaravone, oxiracetam, and gangliosides, they have taken over and become Dinghaishenzhen among neuroprotective drugs. In addition, piracetam, which is a gamma-aminobutyric acid analogue like oxiracetam, has also been recommended by multiple guidelines, bucking the trend and achieving market growth.
Report Covers
This report presents an overview of global Piracetam Injection market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Piracetam Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical
Chongqing Yaoyou Pharmaceutical
Harbin Pharmaceutical Group Sanjing Pharmaceutical
Yangzhou Pharmaceutical
Rapid Life Drugs & Healthcare
Mits Healthcare Private Limited
Psychocare
Shinepro Lifesciences Pvt. Ltd.
REPLEK FARM DOOEL
Dr Reddy's Laboratories Ltd
Heilongjiang Fuhe Pharmaceutical
Segment by Type
15ml
60mL
Other
Segment by Application
Hospital
Clinic
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Piracetam Injection plant distribution, commercial date of Piracetam Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Piracetam Injection introduction, etc. Piracetam Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Piracetam Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
